Pure Red Cell Aplasia
What's New
Last Posted: Mar 07, 2023
- Frequent STAT3 mutations in CD8 T cells from patients with pure red cell aplasia.
Kawakami Toru, et al. Blood advances 2018 0 (20) 2704-2712 - Identification of mutations in patients with acquired pure red cell aplasia.
Zhang Xinchao, et al. Acta biochimica et biophysica Sinica 2018 0 (7) 685-692 - Clonal hematopoiesis in adult pure red cell aplasia.
Fujishima Naohito, et al. Scientific reports 2021 0 (1) 2253 - T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
Kawakami Fumihiro, et al. International journal of hematology 2022 0 (6) 816-825 - Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee Pui Y, et al. The Journal of allergy and clinical immunology 2020 0 (6) 1664-1672.e10 - The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis.
Lonetti Annalisa, et al. Frontiers in physiology 2021 0 745032 - Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services - A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02.
Tan Chuen Wen, et al. Pharmacogenomics 2016 6 - Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
Tanahashi Takahiro, et al. Leukemia research 2016 4 8-13 - STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
Ishida Fumihiro, et al. Cancer science 2014 3 (3) 342-6
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: